David S. Dickens

发表

Impact of Computerized Prescriber Order Entry on the Incidence of Adverse Drug Events in Pediatric Inpatients

David S. Dickens, D. Sinsabaugh, 2008, Pediatrics.

New Roles for Mononuclear Phagocytes in Cancer Biology

David S. Dickens, P. Jubinsky, M. Short, 2008, Journal of pediatric hematology/oncology.

Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.

B. Pollock, A. O'Mara, David S. Dickens, 2016, Journal of oncology practice.

SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities

J. Richman, S. Bhatia, J. Wolfson, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance of Hospital-Acquired Central Line–Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients Lessons Learned, Challenges Ahead

Marlene R. Miller, J. Siegel, D. Bundy, 2013, Infection Control & Hospital Epidemiology.

Barriers to Medication Access in Pediatric Oncology in the United States

David S. Dickens, L. Sung, Michael Kelly, 2019, Journal of pediatric hematology/oncology.

6-Mercaptopurine (6MP) Intake during Maintenance for Childhood Acute Lymphoblastic Leukemia (ALL) - a Comparison of Self-Report and Electronic Monitoring: A Report from the Children's Oncology Group (COG) Study AALL03N1

M. Relling, W. Evans, S. Bhatia, 2015 .

Building competence in pediatric end-of-life care.

David S. Dickens, 2009, Journal of palliative medicine.

Cyclooxygenase-2 Expression Does Not Correlate With Outcome in Osteosarcoma or Rhabdomyosarcoma

P. Leavey, C. Timmons, T. Cripe, 2003, Journal of pediatric hematology/oncology.

Medication prior authorization in pediatric hematology and oncology

David S. Dickens, Brad H. Pollock, 2017, Pediatric blood & cancer.

Characterizing academic performance in pediatric acute lymphoblastic leukemia with population‐based achievement tests

S. Mott, A. Conrad, David S. Dickens, 2021, Cancer reports.

Comparing pediatric deaths with and without hospice support

David S. Dickens, 2010, Pediatric blood & cancer.

Characteristics of pediatric chemotherapy medication errors in a national error reporting database

David S. Dickens, D. Sinsabaugh, J. Fahner, 2008, Cancer.

Therapeutic Strategies for Targeting Mononuclear Phagocytes in Cancer

David S. Dickens, P. Jubinsky, 2009, Journal of pediatric hematology/oncology.

Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemia

David S. Dickens, T. Waters, 2021, Pediatric blood & cancer.

Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs

B. Pollock, David S. Dickens, A. Langevin, 2020, JCO oncology practice.

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.

M. Relling, W. Evans, S. Bhatia, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial.

B. Pollock, David S. Dickens, J. Salsman, 2021, Journal of adolescent and young adult oncology.

Cyclooxygenase-2 Expression in Pediatric Sarcomas

J. Khan, T. Cripe, David S. Dickens, 2002, Pediatric and Developmental Pathology.

Evaluation of the Association Between Congenital Cytomegalovirus Infection and Pediatric Acute Lymphoblastic Leukemia

Lindsay A. Williams, H. Nelson, Y. Ravindranath, 2023, JAMA network open.

Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.

M. Relling, J. Meza, W. Leisenring, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.

M. Relling, W. Evans, S. Bhatia, 2017, Blood.

6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.

M. Relling, W. Evans, J. Neglia, 2014, Blood.

MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia : a Children ’ s Oncology Group study

M. Relling, W. Evans, J. Neglia, 2014 .

Wearable Monitors Facilitate Exercise in Adult and Pediatric Stem Cell Transplant

Lucas J Carr, M. Tomasson, David S. Dickens, 2021, Exercise and sport sciences reviews.

The Menin Inhibitor SNDX-5613 (revumenib) Leads to Durable Responses in Patients (Pts) with KMT2A-Rearranged or NPM1 Mutant AML: Updated Results of a Phase (Ph) 1 Study

J. Dipersio, N. Shukla, I. Aldoss, 2022, Blood.

Successful treatment of an unresectable choroid plexus carcinoma in a patient with Li-Fraumeni syndrome.

David S. Dickens, P. Jubinsky, R. Heideman, 2005, Journal of pediatric hematology/oncology.

Effect of Combined Cyclooxygenase-2 and Matrix Metalloproteinase Inhibition on Human Sarcoma Xenografts

T. Cripe, David S. Dickens, 2003, Journal of pediatric hematology/oncology.

Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report

J. Neglia, A. Angiolillo, Y. Ravindranath, 2022, Cancer.

Clinical Features and Risk Factors Associated With Multisystem Inflammatory Syndrome in Children With Cancer and COVID-19.

S. D. Martin, J. Wolfson, David S. Dickens, 2023, JAMA oncology.

Nonadherence to Oral 6-Mercaptopurine (6MP) in a Multi-Ethnic Cohort of Children with Acute Lymphoblastic Leukemia (ALL) and Its Impact On Relapse – a Children's Oncology Group (COG) Study (AALL03N1)

M. Relling, J. Meza, S. Bhatia, 2012 .

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

S. Armstrong, J. Dipersio, N. Shukla, 2023, Nature.

Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.

M. Relling, J. Meza, W. Leisenring, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.